Order Article Reprints

Sempere A, Egri N, Gonzalez A, Los-Arcos I, Marcos MA, Bernal-Maurandi J, Ruiz-Cabrera D, Dieckmann F, Moreso F, Toapanta N, et al. Utility of the ELISpot Test to Predict the Risk of Developing BK Polyomavirus Nephropathy in Kidney Recipients, a Multicenter Study. Vaccines. 2025; 13(8):796. https://doi.org/10.3390/vaccines13080796

Sempere, Abiu, Natalia Egri, Angela Gonzalez, Ibai Los-Arcos, María Angeles Marcos, Javier Bernal-Maurandi, Diana Ruiz-Cabrera, Fritz Dieckmann, Francesc Moreso, Néstor Toapanta, and et al. 2025. "Utility of the ELISpot Test to Predict the Risk of Developing BK Polyomavirus Nephropathy in Kidney Recipients, a Multicenter Study" Vaccines 13, no. 8: 796. https://doi.org/10.3390/vaccines13080796

Sempere, A., Egri, N., Gonzalez, A., Los-Arcos, I., Marcos, M. A., Bernal-Maurandi, J., Ruiz-Cabrera, D., Dieckmann, F., Moreso, F., Toapanta, N., Pascal, M., & Bodro, M. (2025). Utility of the ELISpot Test to Predict the Risk of Developing BK Polyomavirus Nephropathy in Kidney Recipients, a Multicenter Study. Vaccines, 13(8), 796. https://doi.org/10.3390/vaccines13080796